Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC25013 ARM-1 Featured
A novel LTA4 hydrolase (LTA4H) inhibitor that inhibits LTB4 synthesis in human neutrophils with IC50 of 0.5 uM.
More description
DC22768 MP07-66 Featured
A novel FTY720 analog that acts as PP2A activator, disrupts the SET/PP2A interaction devoid of immunosuppressive effects leads to the reactivation of PP2A.
More description
DC32826 AM-2232 Featured
AM-2232 is a drug that acts as a potent but unselective agonist for the cannabinoid receptors.
More description
DC22223 SB02024 Featured
SB02024 is a novel highly potent, selective, ATP competitive, orally active inhibitor of vacuolar protein sorting 34 (Vps34) with Kd of 1 nM, >1000 times selective towards other PI3K isoenzymes; SB02024 is also highly selective at 1 uM in the DiscoveRx ScanMax panel of 468 kinases; reduces the number of GFP-2xFYVE puncta with IC50 of 14 nM, induces a dose-dependent increase in levels of NCOA4 and p62; blocks autophagy in vitro and reduces xenograft growth of two breast cancer cell lines, MDA-MB-231 and MCF-7; also significantly potentiates cytotoxicity of Sunitinib and Erlotinib in MCF-7 and MDA-MB-231 in vitro.
More description
DC20220 MRS-1845 Featured
MRS 1845 is a potent calcium channel protein inhibitor and inhibits capacitative Ca2+ influx in HL-60 cells (IC50 = 1.7 mM).
More description
DC21825 Guanabenz Featured
Guanabenz (WY 8678) is an α2 adrenergic receptor agonist that is used as an antihypertensive agent, also has been proposed to exert protective effects against misfolding by interfering with eIF2α-P dephosphorylation through selective disruption of a PP1-P
More description
DC10987 LTX-315
This product is discontinued. LTX-315 (Oncopore) is a synthetic 9-mer anticancer peptide that preferentially permeabilizes mitochondrial membranes, thereby causing partially BAX/BAK1-regulated, caspase-independent necrosis.
More description
DC21325 ML 792 Featured
ML 792 is a potent, seletive SUMO-activating enzyme (SAE) inhibitor with IC50 of 3 nM and 11 nM for SAE/SUMO1 and SAE/SUMO2, respectively.
More description
DC11463 Cruzain-IN-1(ML092) Featured
ML092 is a covalent and reversible Cruzain inhibitor, with an IC50 of 10 nM.
More description
DC9820 ML281 Featured
ML281 is a potent and selective STK33 inhibitor with IC50 of 14 nM. ML281 showed a 550-fold selectivity over AurB and greater than 700-fold selectivity over PKA.
More description
DC7198 MLN-120B Featured
MLN120B is a potent and effective IKKbeta inhibitor.
More description
DC12496 Mofezolac Featured
Mofezolac is a Highly Selective Cyclooxygenase-1 Inhibitors,Counteracting Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation.
More description
DC22320 Mollugin Featured
Mollugin is a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway.
More description
DC7690 MMAD Featured
Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate.
More description
DC8339 MPEP hydrochloride Featured
MPEP is a potent, highly selective non-competitive antagonist at the mGlu5a receptor subtype (IC50 = 36 nM) while having no agonist or antagonist activities at the mGlu1b receptor at concentrations up to 30 μM.
More description
DC1015 MPEP Featured
MPEP is a selective mGlu5 receptor antagonist with IC50 of 36 nM.
More description
DC10894 MSDC-0602 Featured
MSDC-0602 is an insulin sensitizer potentially for the treatment of diabetes.
More description
DC20230 mTOR inhibitor-1 Featured
mTOR inhibitor-1 is a novel mTOR pathway inhibitor which can suppress cells proliferation and inducing autophagy.
More description
DC26051 MX1013 Featured
MX1013 is a dipeptide pan-caspase inhibitor that inhibits caspase-1
More description
DC8492 Naloxegol Oxalate(NKTR-118) Featured
Naloxegol is the first oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation.
More description
DC8407 Naloxone HCl Dihydrate Featured
Naloxone HCl Dihydrate is an opioid inverse agonist drug used to counter the effects of opiate overdose.
More description
DC10551 Necrostatin 2 racemate Featured
Necrostatin 2 is a potent necroptosis inhibitor with EC50 of 50 nM.
More description
DC8290 (S)-PFI-2 HCl Featured
Negative control of (R)-PFI 2 hydrochloride. Exhibits 500-fold lower activity in a SETD7 enzymatic assay (IC50 = 1 μM) compared to the active enantiomer.
More description
DC23087 Neoandrographolide Featured
Neoandrographolide has antiradical, anti-inflammatory,and hypolipidemic effects, it protects the cardiovascular without significant liver damage. Neoandrographolide as chemosensitizer in S-Jurkat and X chromosome-linked inhibitor of apoptosis protein (XIA
More description
DC11281 NGI-1 (ML414) Featured
NGI-1 (ML414) is a potent, cell-permeable oligosaccharyltransferase (OST) inhibitor with IC50 of 1.1 uM.
More description
DC7758 Nimorazole Featured
Nimorazole is a nitroimidazole anti-infective.
More description
DC10549 Nomifensine maleate Featured
Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
More description
DC10453 NP-118809 Featured
NP-118809 is a N-type calcium channel blocker.
More description
DC9608 NS-304(Selexipag) Featured
NS-304(Selexipag; ACT-293987) is an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension.
More description
DC10603 NSC 247030(SU5201) Featured
NSC 247030 is a bioactive chemical.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X